Business & regional news

Month Year

Month Year

Mar 5, 2023

Medtronic Evolut™ TAVR platform shows excellent valve performance and durability in low-risk aortic stenosis patients

ACC.23/WCC Late-Breaking Clinical Trial: Evolut™ is only TAVR to show excellent outcomes in low-risk patients at 3 years
- Structural Heart and Aortic
- Photos 1
Feb 27, 2023

Medtronic CoreValve/Evolut™ demonstrates best durability

CRT 2023 Late-Breaking Data: CoreValve/Evolut™ platform demonstrates significantly lower bioprosthetic valve dysfunction compared to surgery at five years
- Structural Heart and Aortic
Feb 22, 2023

Medtronic relaunches first-of-its-kind transcatheter pulmonary valve replacement system for congenital heart disease

Harmony™ Transcatheter Pulmonary Valve System is the first FDA-approved minimally invasive valve designed for the right side of the heart
- Structural Heart and Aortic
Jan 11, 2023

Medtronic announces first enrollment in head-to-head global randomized trial evaluating durability of endovascular aneurysm repair

ADVANCE Trial compares sac regression in the Medtronic Endurant™ II/IIs stent graft system and the Gore® Excluder®* AAA Device Family systems
- Structural Heart and Aortic
Nov 29, 2022

Medtronic’s Next-Gen Evolut™ FX TAVR System Shows Significant Improvement in Commissure Alignment in Real World Setting

London Valves 2022: Latest Transcatheter Aortic Valve Replacement Data for Treatment of Aortic Stenosis and Prosthetic Aortic Valve Degeneration
- Structural Heart and Aortic

Show per page